System and Method for Wireless Stack Implementation on Multiple Wireless Devices
    103.
    发明申请
    System and Method for Wireless Stack Implementation on Multiple Wireless Devices 审中-公开
    多种无线设备无线堆栈实现的系统和方法

    公开(公告)号:US20130188556A1

    公开(公告)日:2013-07-25

    申请号:US13577397

    申请日:2011-02-02

    Abstract: The present invention relates to a Wireless Communication System (100) for enabling parts of a wireless stack (106) to physically run on multiple wireless devices, connected together by a wireless link (110). The system (100) comprises at least one peer device (102), having at least one application module (104) for at least one embedded device (112), a data routing entity (108) for communicating with the embedded device (112) and at least a part of one or more wireless stacks (106); the embedded device being configured to execute the at least one application (104a, 104b, 104c, 104d), on establishing a connection between the embedded device (112) and the peer device (102), wherein a data routing entity (114) in the embedded device (112) is configured to communicate with the peer device (102).

    Abstract translation: 无线通信系统本发明涉及无线通信系统(100),其用于使无线栈(106)的部分在无线链路(110)连接在一起的多个无线设备上物理运行。 所述系统(100)包括至少一个对等设备(102),其具有用于至少一个嵌入式设备(112)的至少一个应用模块(104),用于与所述嵌入式设备(112)进行通信的数据路由实体(108) 以及一个或多个无线栈(106)的至少一部分; 所述嵌入式设备被配置为在所述嵌入式设备(112)和所述对等设备(102)之间建立连接时执行所述至少一个应用(104a,104b,104c,104d),其中,数据路由实体(114) 嵌入式设备(112)被配置为与对等设备(102)通信。

    Steroidal esters of 17-oximino-5-androsten-3beta-ol
    104.
    发明授权
    Steroidal esters of 17-oximino-5-androsten-3beta-ol 有权
    17-肟基-5-雄甾-3β-醇的甾体酯

    公开(公告)号:US08435975B2

    公开(公告)日:2013-05-07

    申请号:US12733415

    申请日:2008-08-14

    CPC classification number: C07J41/0016

    Abstract: The present invention relates to steroidal esters of 17-oximino-5-androsten-3-ol, of compound of general formula (A) wherein R is selected from a group consisting of arylalkyl, aryl, substituted aryl. The ester derivatives are synthesized starting from Dehydroandrosterone acetate. The compounds were tested for their antiproliferative activity and 5α-reductase inhibitory activity in comparison to Finasteride. Decreased androgen level have been found in serum of animal treated with newly synthesized compounds. These compounds have also shown better cytotoxicity in comparison to reference drug Finasteride. Thus such compounds can be useful in treatment of androgen dependent disorder of prostate alone or by synergistic effect they can decrease the size of prostate due to their antiproliferative activity.

    Abstract translation: 本发明涉及通式(A)化合物,其中R选自芳烷基,芳基,取代芳基的17-肟基-5-雄甾-3-醇类甾体酯。 酯衍生物是从乙酸脱氢睾酮开始合成的。 与非那雄胺相比,测试化合物的抗增殖活性和5α-还原酶抑制活性。 在新合成的化合物处理的动物血清中发现雄激素水平降低。 与参考药物非那雄胺相比,这些化合物也显示出更好的细胞毒性。 因此,这样的化合物可用于治疗前列腺单独的雄激素依赖性病症或通过协同作用,由于它们的抗增殖活性,它们可以减少前列腺的大小。

    METHOD FOR MODIFYING NON-STARCH CARBOHYDRATE MATERIAL USING PEROXIDASE ENZYME
    110.
    发明申请
    METHOD FOR MODIFYING NON-STARCH CARBOHYDRATE MATERIAL USING PEROXIDASE ENZYME 审中-公开
    使用过氧化物酶修饰非淀粉状碳酸酯材料的方法

    公开(公告)号:US20110189727A1

    公开(公告)日:2011-08-04

    申请号:US13054178

    申请日:2009-07-10

    CPC classification number: C12P7/10 C12P19/02 Y02E50/16

    Abstract: A method for the modification of a material comprising a non-starch carbohydrate, which method comprises contacting said material comprising a non-starch carbohydrate with a polypeptide which has peroxidase activity and which is: a. a polypeptide comprising an amino acid sequence having at least 55% homology with an amino acid sequence set out in any one of: amino acids 21 to 513 of SEQ NO: 2; amino acids 20 to 510 of SEQ ID NO: 4; amino acids 1 to 493 of SEQ ID NO 6; or amino acids 1 to 491 of SEQ ID NO: 8 or b. a polypeptide encoded by a polynucleotide comprising the nucleotide sequence having at least 55% homology with a nucleotide sequence set out in any one of: nucleotides 61 to 1539 of SEQ ID NO: 1; nucleotides 58 to 1530 of SEQ ID NO: 3; nucleotides 1 to 1479 of SEQ ID NO: 5; or nucleotides 1 to 1473 of SEQ ID NO: 7.

    Abstract translation: 一种用于修饰包含非淀粉碳水化合物的材料的方法,该方法包括使包含非淀粉碳水化合物的所述材料与具有过氧化物酶活性的多肽接触,并且其是:a。 一种多肽,其包含与SEQ ID NO:2的氨基酸21至513中任一个所示的氨基酸序列具有至少55%的同源性的氨基酸序列; SEQ ID NO:4的氨基酸20至510; SEQ ID NO:6的氨基酸1至493; 或SEQ ID NO:8的氨基酸1至491或b。 由多核苷酸编码的多肽,其包含与SEQ ID NO:1的核苷酸61至1539中任一个所示的核苷酸序列具有至少55%的同源性的核苷酸序列; SEQ ID NO:3的核苷酸58至1530; SEQ ID NO:5的核苷酸1至1479; 或SEQ ID NO:7的核苷酸1至1473。

Patent Agency Ranking